Although there are emerging diagnostic biomarkers for the detection of PCa (2, 3), PCa is usually diagnosed by prostate biopsy prompted by a blood test to measure prostate-specific antigen (PSA) levels and/or digital rectal examination. This evidence concerns the gene KLK3 and posterior cortical atrophy.